ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Cancer Meetings Listed for Next Three Months

January 19, 1996

Abstracts of Papers From ASCO Meeting

April 14, 1978

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

NCCN Publishes Anemia Guidelines

April 12, 2002

NCI Preliminary Budge For 1979 By Mechanism

June 3, 1977